Immunotherapy and the novel therapeutic development for small-cell lung cancer
Therapeutic Advances in Medical Oncology
Published online on July 27, 2026
Abstract
Therapeutic Advances in Medical Oncology, Volume 18, January-December 2026.
Small-cell lung cancer (SCLC) is broadly classified into limited- (LS) and extensive-stage (ES) disease, with distinct therapeutic approaches and outcomes. Despite high initial response rates, most patients eventually experience disease progression, ...
Small-cell lung cancer (SCLC) is broadly classified into limited- (LS) and extensive-stage (ES) disease, with distinct therapeutic approaches and outcomes. Despite high initial response rates, most patients eventually experience disease progression, ...